Form 990 for tax year 2025
Filed by INSTITUTE FOR IN VITRO SCIENCES INC.
Totals
- Total revenue
- $7,901,249
- Total expenses
- $7,883,164
- Contributions and grants received
- $793,498
- Grants paid
- $0
- Program service revenue
- $7,069,056
- Investment income
- $5,626
- Other revenue
- $33,069
- Total assets, end of year
- $5,555,372
- Total liabilities, end of year
- $3,178,014
- Net assets or fund balances, end of year
- $2,377,358
- Program services expenses (Part IX)
- $7,399,857
- Management and general expenses
- $462,888
- Fundraising expenses
- $20,419
- Program service expenses (Part III)
- $7,399,857
Program services were 93.9% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.
Line items
Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.
Revenue
Part VIII, the statement of revenue.
-
1e · Government grants (contributions)
$38,826
-
1f · All other contributions, gifts and grants
$754,672
-
2a · Program service revenue: RESEARCH AND TESTING
total $6,805,283 · related or exempt $6,805,283
-
2b · Program service revenue: EDUCATIONAL ACTIVITIES
total $263,773 · related or exempt $263,773
-
3 · Investment income
total $5,626 · excluded $5,626
-
11a · Other revenue: REIMBURSEMENTS
total $27,604 · excluded $27,604
-
11b · Other revenue: REFUND
total $5,465 · excluded $5,465
-
11e · Other revenue, total
$33,069
Functional expenses
Part IX, the statement of functional expenses.
-
5 · Compensation of officers, directors and key employees
total $354,961 · program services $255,863 · management and general $85,190 · fundraising $13,908
-
7 · Other salaries and wages
total $3,454,068 · program services $3,261,002 · management and general $193,066
-
8 · Pension plan contributions
total $103,929 · program services $101,109 · management and general $2,820
-
9 · Other employee benefits
total $354,273 · program services $338,970 · management and general $14,920 · fundraising $383
-
10 · Payroll taxes
total $287,808 · program services $272,173 · management and general $14,866 · fundraising $769
-
11b · Fees: legal
total $7,215 · management and general $7,215
-
11c · Fees: accounting
total $58,919 · management and general $58,919
-
11g · Fees: other
total $211,116 · program services $210,965 · management and general $143 · fundraising $8
-
12 · Advertising and promotion
total $30,416 · program services $30,416
-
13 · Office expenses
total $51,849 · program services $50,088 · management and general $1,660 · fundraising $101
-
14 · Information technology
total $226,463 · program services $207,205 · management and general $18,850 · fundraising $408
-
15 · Royalties
total $1,953 · program services $1,953
-
16 · Occupancy
total $546,566 · program services $516,886 · management and general $28,223 · fundraising $1,457
-
17 · Travel
total $169,703 · program services $165,316 · management and general $3,160 · fundraising $1,227
-
19 · Conferences, conventions and meetings
total $16,312 · program services $15,758 · management and general $554
-
20 · Interest
total $12,392 · program services $11,975 · management and general $396 · fundraising $21
-
22 · Depreciation, depletion and amortization
total $234,005 · program services $223,063 · management and general $10,401 · fundraising $541
-
23 · Insurance
total $95,943 · program services $77,931 · management and general $17,791 · fundraising $221
-
24a · Other expenses: LABORATORY EXPENSES
total $1,647,390 · program services $1,647,390
-
24b · Other expenses: DUES/MEMBERSHIPS/PUBS.
total $12,210 · program services $11,601 · management and general $609
-
24c · Other expenses: PENALTIES & FINES
total $4,105 · management and general $4,105
-
24d · Other expenses: LICENSE FEES & PERMITS
total $1,568 · program services $193 · fundraising $1,375
Balance sheet
Part X, book values.
-
1 · Cash, non-interest-bearing
beginning of year $71,138 · end of year $65,201
-
2 · Savings and temporary cash investments
beginning of year $648,096 · end of year $613,203
-
3 · Pledges and grants receivable
beginning of year $107,162 · end of year $255,346
-
4 · Accounts receivable
beginning of year $1,851,300 · end of year $1,953,690
-
9 · Prepaid expenses and deferred charges
beginning of year $126,073 · end of year $137,054
-
10a · Land, buildings and equipment: cost or other basis
$2,535,985
-
10b · Land, buildings and equipment: accumulated depreciation
$1,823,694
-
10c · Land, buildings and equipment, net
beginning of year $872,411 · end of year $712,291
-
15 · Other assets
beginning of year $2,249,573 · end of year $1,818,587
-
17 · Accounts payable and accrued expenses
beginning of year $570,660 · end of year $605,953
-
19 · Deferred revenue
beginning of year $215,975 · end of year $303,135
-
23 · Secured mortgages and notes payable
beginning of year $161,716 · end of year $125,556
-
25 · Other liabilities
beginning of year $2,618,129 · end of year $2,143,370
-
27 · Net assets without donor restrictions
beginning of year $2,334,273 · end of year $2,333,200
-
28 · Net assets with donor restrictions
beginning of year $25,000 · end of year $44,158
Mission and programs · 2025
Mission
THE MISSION OF THE INSTITUTE FOR IN VITRO SCIENCES (IIVS) IS TO DRIVE THE OPTIMIZATION AND APPLICATION OF SCIENTIFICALLY ROBUST IN VITRO METHODS THAT ARE ACCEPTED BY REGULATORY AGENCIES AND ADOPTED BY INDUSTRY WORLDWIDE. TO CREATE A FORUM IN WHICH INDUSTRY, REGULATORY AGENCIES AND ANIMAL WELFARE ORGANIZATIONS CAN WORK TOGETHER TO DEVELOP HUMANE SCIENTIFIC TOOLS FOR TESTING. TO UTILIZE OUR EXPERTISE TO CREATE EDUCATIONAL AND OUTREACH PROGRAMS THAT WILL EXPAND THE ADOPTION OF NON-ANIMAL TEST METHODS AROUND THE GLOBE.
Activities or mission (Part I)
TO INCREASE THE USE AND ACCEPTANCE OF NON-ANIMAL TEST METHODS WORLDWIDE.
-
RESEARCH AND TESTING: IIVS WORKED WITH MORE THAN SIXTY COMPANIES TO DETERMINE THE APPROPRIATE NON-ANIMAL TESTING STRATEGIES, CONDUCT TESTING, AND ASSIST IN INTERPRETATION OF DATA. OVER 880 COMPOUNDS/PRODUCTS WERE TESTED AT THE IIVS LABORATORY - MOSTLY IN MORE THAN ONE TEST. IIVS CONTINUES TO OPTIMIZE AND STANDARDIZE IN VITRO METHODS TO MAKE THEM SUITABLE FOR INDUSTRY AND REGULATORY NEEDS. MANY OF THESE EFFORTS ARE IN COLLABORATION WITH STAKEHOLDERS SUCH AS INDUSTRY, GOVERNMENT AND NGOS. ADVANCEMENTS ARE SHARED WITH THE SCIENTIFIC COMMUNITY THROUGH PRESENTATIONS AND PUBLICATIONS SO THAT OTHER INDUSTRIES AND REGULATORY SCIENTISTS CAN BENEFIT. IIVS HAS DEVELOPED AND PROMOTED THE USE OF HUMAN PRECISION CUT LUNG SLICES (HPCLS) FOR POTENTIAL REGULATORY APPLICATION AS AN ALTERNATIVE TO USING ANIMALS FOR INHALATION AND RESPIRATORY ENDPOINTS. BASED UPON OUR SUCCESSFUL USE OF HPCLS IN IN-HOUSE STUDIES, STAKEHOLDERS HAVE INQUIRED WHETHER THEY COULD PROCURE THESE HPCLS TISSUES FOR USE WITHIN THEIR OWN LABORATORIES. IIVS PREPARED AND QUALIFIED HPCLS TISSUES FOR 30 SPONSOR-RUN LABORATORY STUDIES THAT WOULD HAVE OTHERWISE USED ANIMALS.
Expenses $6,332,999 · Revenue $6,805,283
-
EDUCATION AND OUTREACH: IIVS PARTICIPATES IN NUMEROUS TRAINING ACTIVITIES FOR A VARIETY OF STAKEHOLDERS INCLUDING INDUSTRY AND REGULATORY SCIENTISTS. THESE TRAININGS ARE TAILORED FOR THE SPECIFIC AUDIENCE AND GENERALLY INCLUDE LECTURES, HANDS-ON DEMONSTRATIONS AND DATA INTERPRETATION. TWO MAJOR PROGRAMS IN WHICH IIVS PARTICIPATES ARE THE PHYSICIANS COMMITTEE FOR RESPONSIBLE MEDICINE NURA TRAINING AND THE ANIMAL FREE SAFETY ASSESSMENT COLLABORATION COORDINATED BY HUMANE SOCIETY INTERNATIONAL. IIVS SCIENTISTS WERE INVITED TO PARTICIPATE IN EXPERT PANELS CONVENED BY THE ORGANIZATION FOR ECONOMIC COOPERATION AND DEVELOPMENT (OECD) WHICH HARMONIZES IN VITRO TESTING APPROACHES FOR THE WORLDWIDE SCIENTIFIC COMMUNITY. THESE PANELS DISCUSSED NEW METHODS FOR GENETIC TOXICOLOGY, SKIN SENSITIZATION, EYE IRRITATION AND SKIN CORROSION. IIVS IS LEADING EFFORTS WITH INDUSTRY CONSORTIA AND 2 DIVISIONS OF THE U.S. FEDERAL DRUG ADMINISTRATION TO APPLY NON-ANIMAL METHODS FOR SPECIFIC ENDPOINTS. IIVS IS ALSO INVOLVED IN EFFORTS TO SUPPORT THE U.S. ENVIRONMENTAL PROTECTION AGENCY'S GOAL TO REDUCE RELIANCE ON ANIMAL MODELS. IIVS STAFF HOLD BOARD POSITIONS WITHIN SOCIETIES THAT HAVE THE MISSION TO WORK COLLABORATIVELY TO INCREASE THE USE AND ACCEPTANCE OF ALTERNATIVE METHODS, SUCH AS THE AMERICAN SOCIETY FOR CELLULAR AND COMPUTATIONAL TOXICOLOGY, THE EUROPEAN SOCIETY OF TOXICOLOGY IN VITRO, THE U.S. SOCIETY OF TOXICOLOGY AND THE CHINESE SOCIETY OF TOXICOLOGY.
Expenses $1,066,858 · Revenue $263,773
As filed on the 2025 return. The filer continues this part on Schedule O, which is not shown here.
Listed in Part VII
-
Amanda K UlreyAMANDA K ULREY
PRESIDENT
- Total calculated
- $167,797
- From this org
- $160,387
- From related orgs
- $0
- Other
- $7,410
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $160,387
- Bonus
- $0
- Other
- $0
- Deferred
- $6,408
- Nontaxable benefits
- $1,002
- Filer's total
- $167,797
-
Hans A RaabeHANS A RAABE
CHIEF OPERATING OFFICER/TREASURER
- Total calculated
- $172,796
- From this org
- $152,576
- From related orgs
- $0
- Other
- $20,220
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $152,576
- Bonus
- $0
- Other
- $0
- Deferred
- $6,577
- Nontaxable benefits
- $13,643
- Filer's total
- $172,796
-
Rodger D CurrenRODGER D CURREN
CEO/BOARD CHAIR/SECRETARY
- Total calculated
- $14,368
- From this org
- $13,815
- From related orgs
- $0
- Other
- $553
- Hours/week
- 10
-
Daniel A BagleyDANIEL A BAGLEY
DIRECTOR
- Total calculated
- $0
- Hours/week
- 0.5
-
John R FowleJOHN R FOWLE
DIRECTOR
- Total calculated
- $0
- Hours/week
- 0.5
-
A Wallace HayesA WALLACE HAYES
DIRECTOR
- Total calculated
- $0
- Hours/week
- 0.5
-
James M HoffmanJAMES M HOFFMAN
DIRECTOR
- Total calculated
- $0
- Hours/week
- 0.5
-
Richard E KouriRICHARD E KOURI
DIRECTOR
- Total calculated
- $0
- Hours/week
- 0.5
-
Holger P BehrsingHOLGER P BEHRSING
DIRECTOR RESPIRATORY TOXICOLOGY
- Total calculated
- $181,262
- From this org
- $165,396
- From related orgs
- $0
- Other
- $15,866
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $165,396
- Bonus
- $0
- Other
- $0
- Deferred
- $6,590
- Nontaxable benefits
- $9,276
- Filer's total
- $181,262
-
Gertrude-Emilia CostinGERTRUDE-EMILIA COSTIN
DIRECTOR OF LABORATORY SERVICES
- Total calculated
- $165,543
- From this org
- $153,460
- From related orgs
- $0
- Other
- $12,083
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $153,460
- Bonus
- $0
- Other
- $0
- Deferred
- $0
- Nontaxable benefits
- $12,083
- Filer's total
- $165,543
-
Allison M HilbererALLISON M HILBERER
TOXICOLOGIST II/STUDY DIRECTOR
- Total calculated
- $136,837
- From this org
- $123,067
- From related orgs
- $0
- Other
- $13,770
- Hours/week
- 40
-
Nathan R WiltNATHAN R WILT
STUDY DIRECTOR
- Total calculated
- $135,109
- From this org
- $121,135
- From related orgs
- $0
- Other
- $13,974
- Hours/week
- 40
-
Kristie M SullivanKRISTIE M SULLIVAN
VP, EDUCATION AND OUTREACH
- Total calculated
- $123,055
- From this org
- $117,318
- From related orgs
- $0
- Other
- $5,737
- Hours/week
- 40
Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us.
Schedule J
Answered yes
- 3 · Form 990 of other organizations
- 3 · Compensation survey or study
- 3 · Approval by the board or compensation committee
Answered no
- 4a · Severance or change-of-control payment
- 4b · Supplemental nonqualified retirement plan
- 4c · Equity-based compensation arrangement
- 5a · Pay contingent on this organization's revenues
- 5b · Pay contingent on a related organization's revenues
- 6a · Pay contingent on this organization's net earnings
- 6b · Pay contingent on a related organization's net earnings
- 7 · Other non-fixed payments
- 8 · Paid under the initial-contract exception
Part I's answers as filed. A line not listed was left unanswered; on lines 1a and 3 that means the box was not checked.
Grants on this return
No itemized grants to organizations on this return.
Provenance
- Return type
- form_990
- Tax year
- 2025
- Filed
- 6 August 2026
- IRS schema version
- 2025v4.2
- Source object
- 202642189349301704
Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.
The source document this was parsed from is served over the API, which is where bulk and document access live.